西维斯健康CVS Health（CVS）2025年第四季度及全年业绩报告「NYSE」（英文版）（25页）.pdf

1、Exhibit 99.1 CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS Fourth Quarter HighlightsTotal revenues increased to$105.7 billion,up 8.2%compared to prior yearGAAP diluted EPS of$2.30 and Adjusted EPS of$1.09Full-Year HighlightsTotal revenues increased to a record high$402.1 b

2、illion,up 7.8%compared to prior yearGAAP diluted EPS of$1.39 and Adjusted EPS of$6.75Generated cash flow from operations of$10.6 billionOperational HighlightsCVS Pharmacy successfully completed the transition to cost-based reimbursement across its Commercial,Third-Party Discount,Medicare and Medicai

3、d businesses.Aetna continues to improve the experience for health care professionals and their patients,approving more than 95%of all eligible prior authorizations within 24 hours,with many completed instantaneously.Caremark closes out 2025 with significant customer wins and strong retention,providi

4、ng momentum into 2026.2026 Full-Year GuidanceConfirmed GAAP diluted EPS guidance range of$5.94 to$6.14Confirmed Adjusted EPS guidance range of$7.00 to$7.20Updated cash flow from operations guidance to at least$9.0 billion from at least$10.0 billionCEO Commentary“Our fourth quarter and full-year resu

5、lts demonstrate the progress we are making in transforming the health care experience with our unique collection of businesses.From lowering drug prices,to improving navigation of health care,to being the front door of care across our country,we are well positioned to achieve our ambition to be the

6、most trusted health care company in America.”-David Joyner,CVS Health President and CEOWOONSOCKET,RHODE ISLAND,February 10,2026-CVS Health Corporation(NYSE:CVS)today announced operating results for the three months and year ended December 31,2025.Financial Results SummaryThree Months Ended December